98 related articles for article (PubMed ID: 30605979)
1. [Influence of UCHL5 on proliferation and apoptosis of SW527 breast cancer cells].
Ding F; Ma JL; Wu XW; Liu ZH
Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):900-904. PubMed ID: 30605979
[No Abstract] [Full Text] [Related]
2. Downregulation of ubiquitin-specific protease 14 (USP14) inhibits breast cancer cell proliferation and metastasis, but promotes apoptosis.
Zhu L; Yang S; He S; Qiang F; Cai J; Liu R; Gu C; Guo Z; Wang C; Zhang W; Zhang C; Wang Y
J Mol Histol; 2016 Feb; 47(1):69-80. PubMed ID: 26712154
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer.
Zhang HD; Jiang LH; Hou JC; Zhong SL; Zhou SY; Zhu LP; Li J; Wang DD; Sun DW; Ji ZL; Tang JH
Biomed Pharmacother; 2018 Nov; 107():1342-1353. PubMed ID: 30257349
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
5. Integrin α7 high expression correlates with deteriorative tumor features and worse overall survival, and its knockdown inhibits cell proliferation and invasion but increases apoptosis in breast cancer.
Bai X; Gao C; Zhang L; Yang S
J Clin Lab Anal; 2019 Oct; 33(8):e22979. PubMed ID: 31325216
[TBL] [Abstract][Full Text] [Related]
6. Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance.
Zeng C; Ke Z; Song Y; Yao Y; Hu X; Zhang M; Li H; Yin J
Exp Mol Pathol; 2013 Aug; 95(1):23-31. PubMed ID: 23631820
[TBL] [Abstract][Full Text] [Related]
7. Effects of RNA interference-mediated NRP-1 silencing on the proliferation and apoptosis of breast cancer cells.
Han Z; Jiang G; Zhang Y; Xu J; Chen C; Zhang L; Xu Z; Du X
Mol Med Rep; 2015 Jul; 12(1):513-9. PubMed ID: 25738638
[TBL] [Abstract][Full Text] [Related]
8. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
Han W; Cao F; Gao XJ; Wang HB; Chen F; Cai SJ; Zhang C; Hu YW; Ma J; Gu X; Ding HZ
Int J Oncol; 2018 Sep; 53(3):937-948. PubMed ID: 29956756
[TBL] [Abstract][Full Text] [Related]
9. C-terminal binding protein-2 promotes cell proliferation and migration in breast cancer via suppression of p16INK4A.
Yang X; Sun Y; Li H; Shao Y; Zhao D; Yu W; Fu J
Oncotarget; 2017 Apr; 8(16):26154-26168. PubMed ID: 28412731
[TBL] [Abstract][Full Text] [Related]
10. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-223 Targeting STIM1 Inhibits the Biological Behavior of Breast Cancer.
Yang Y; Jiang Z; Ma N; Wang B; Liu J; Zhang L; Gu L
Cell Physiol Biochem; 2018; 45(2):856-866. PubMed ID: 29414804
[TBL] [Abstract][Full Text] [Related]
12. Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1.
Li Y; Zhang Y; Liu X; Wang M; Wang P; Yang J; Zhang S
Int J Oncol; 2018 Jun; 52(6):2119-2129. PubMed ID: 29620169
[TBL] [Abstract][Full Text] [Related]
13. Effects of DCK knockdown on proliferation, apoptosis and tumorigenicity in vivo of cervical cancer HeLa cells.
Shang QY; Wu CS; Gao HR
Cancer Gene Ther; 2017 Sep; 24(9):367-372. PubMed ID: 28820179
[TBL] [Abstract][Full Text] [Related]
14. Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer.
Choi HJ; Joo HS; Won HY; Min KW; Kim HY; Son T; Oh YH; Lee JY; Kong G
J Natl Cancer Inst; 2018 Apr; 110(4):. PubMed ID: 29028222
[TBL] [Abstract][Full Text] [Related]
15. Berberine Inhibits Proliferative Ability of Breast Cancer Cells by Reducing Metadherin.
Sun Y; Wang W; Tong Y
Med Sci Monit; 2019 Nov; 25():9058-9066. PubMed ID: 31779025
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of Notch-regulated Ankyrin Repeat Protein Exerts Antitumor Activities against Growth of Thyroid Cancer.
Chu BF; Qin YY; Zhang SL; Quan ZW; Zhang MD; Bi JW
Chin Med J (Engl); 2016 Jul; 129(13):1544-52. PubMed ID: 27364790
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of TNFRSF14 indicates good prognosis and inhibits bladder cancer proliferation by promoting apoptosis.
Zhu YD; Lu MY
Mol Med Rep; 2018 Sep; 18(3):3403-3410. PubMed ID: 30066919
[TBL] [Abstract][Full Text] [Related]
19. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.
Huang N; Wu Z; Hong H; Wang X; Yang F; Li H
Mol Med Rep; 2019 Jun; 19(6):4761-4769. PubMed ID: 30957190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]